Medicine Man Technologies, Inc. (SHWZ)
| Market Cap | 86.00 -100.0% |
| Revenue (ttm) | 174.91M +5.5% |
| Net Income | -67.86M |
| EPS | -0.91 |
| Shares Out | 85.61M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | 76.12 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Mar 30, 2026 |
About Medicine Man Technologies
Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico. It operates through Retail, Wholesale, and Others segments. The company offers loose flower, concentrates, edibles, pre-rolls, topicals, infused beverages, and other associated cannabis products produced by cannabis vendors; and cannabis and non-cannabis products. It operates retail cannabis dispensaries under the Star Buds, Emerald Fields, Sta... [Read more]
Financial Performance
In 2023, Medicine Man Technologies's revenue was $172.45 million, an increase of 8.20% compared to the previous year's $159.38 million. Losses were -$42.70 million, 62.6% more than in 2022.
Financial StatementsNews
Vireo Growth closes acquisition of Schwazze convertible notes
Vireo Growth (VREOF) closed on a transaction to acquire outstanding senior secured convertible notes of public U.S. multi-state cannabis operator, Medicine Man Technologies (SHWZ). The Company simulta...
Schwazze reaches agreement to restructure balance sheet, portfolio of assets
Medicine Man Technologies, Inc., operating as Schwazze (SHWZ) entered into a Restructuring Support Agreement with an affiliate of Vireo Growth (VREOF), which holds a majority of the Company’s outstand...
Schwazze provides update on delayed filings
Medicine Man Technologies, operating as Schwazze (SHWZ), is providing an update on its previously announced delayed filings. The company said, “On November 29, 2024, the Audit Committee of the Company...
Schwazze Provides Update on Delayed Filings
DENVER, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Medicine Man Technologies, Inc., operating as Schwazze, (OTC: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), is providing an update on its previously an...
Medicine Man Technologies Earnings Call Transcript: Q2 2024
Q2 2024 revenue rose 2% to $43.2M, with market share gains in both Colorado and New Mexico despite pricing pressures and a drop in gross margin. Operational restructuring, store closures, and debt extension improved financial flexibility, while regulatory and audit challenges remain.
Medicine Man Technologies Earnings release: Q2 2024
Medicine Man Technologies released its Q2 2024 earnings on August 13, 2024, summarizing the period's financial results.
Schwazze Sets Second Quarter 2024 Conference Call for August 13, 2024 at 5:00 p.m. ET
DENVER, July 30, 2024 (GLOBE NEWSWIRE) -- Medicine Man Technologies, Inc., operating as Schwazze, (OTC: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Tuesday, Aug...
Schwazze Announces Restructuring of February 2025 Debt Obligations
DENVER, Colo., July 11, 2024 (GLOBE NEWSWIRE) -- Medicine Man Technologies, Inc., operating as Schwazze, (OTCPK: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), today announced that it has finali...
Schwazze Announces Transition to OTC Expert Market and Provides Update on Delayed Filing
DENVER, July 01, 2024 (GLOBE NEWSWIRE) -- Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), today announced that its common stock wil...
Schwazze Announces Grand Opening of its 35th New Mexico Dispensary in Bernalillo
DENVER, June 07, 2024 (GLOBE NEWSWIRE) -- Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), today announced the grand opening of its ...
Medicine Man Technologies Earnings Call Transcript: Q1 2024
Medicine Man Technologies Earnings release: Q1 2024
Medicine Man Technologies released its Q1 2024 earnings on May 15, 2024, summarizing the period's financial results.
Schwazze Announces First Quarter 2024 Financial Results
Schwazze Management to Host Conference Call Today at 5:00 p.m. Eastern Time DENVER , May 15, 2024 /PRNewswire/ - Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) (...
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
DENVER , April 29, 2024 /PRNewswire/ - Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Wednesday, Ma...
Medicine Man Technologies Proxy statement: Proxy Filing
Medicine Man Technologies filed a proxy statement on April 29, 2024, providing details for shareholder voting and corporate governance matters.
Medicine Man Technologies Proxy statement: Proxy Filing
Medicine Man Technologies filed a proxy statement on April 29, 2024, providing details for shareholder voting and corporate governance matters.
Medicine Man Technologies Earnings Call Transcript: Q4 2023
Medicine Man Technologies Annual report: Q4 2023
Medicine Man Technologies has published its Q4 2023 annual report on March 27, 2024.
Medicine Man Technologies Earnings release: Q4 2023
Medicine Man Technologies released its Q4 2023 earnings on March 27, 2024, summarizing the period's financial results.
Schwazze Announces Fourth Quarter and Full Year 2023 Financial Results
FY 2023 Revenue of $172.4 Million; Income from Operations of $3.3 Million; Adjusted EBITDA of $53.4 Million or 31% of Revenue Generated $12.2 Million of Operating Cash Flow in FY 2023 DENVER , March ...
Schwazze Sets Fourth Quarter and Full Year 2023 Conference Call for March 27, 2024 at 5:00 p.m. ET
DENVER , March 12, 2024 /PRNewswire/ - Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Wednesday, March...
From Seed to Profit: The Top Cannabis Penny Stocks to Watch
Diving into the dynamic world of U.S. marijuana stocks offers a glimpse into a sector pulsing with growth and brimming with investment prospects. This burgeoning market has captured investors' attenti...
Schwazze Appoints Forrest Hoffmaster as Interim Chief Executive Officer
DENVER, Feb. 23, 2024 /PRNewswire/ - Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (NEO: SHWZ) ("Schwazze" or the "Company"), today announced that Forrest Hoffmaster, the Compa...
Medicine Man Technologies Earnings Call Transcript: Q3 2023
Medicine Man Technologies Quarterly report: Q3 2023
Medicine Man Technologies has published its Q3 2023 quarterly earnings report on November 14, 2023.